4//SEC Filing
Vogt Frederick G 4
Accession 0001104659-25-118168
CIK 0001425205other
Filed
Dec 2, 7:00 PM ET
Accepted
Dec 3, 5:01 PM ET
Size
15.1 KB
Accession
0001104659-25-118168
Insider Transaction Report
Form 4
Vogt Frederick G
DirectorInterim CEO & General Counsel
Transactions
- Exercise/Conversion
Common Stock
2025-12-01+41,669→ 476,232 total - Tax Payment
Common Stock
2025-12-01$2.23/sh−17,701$39,473→ 458,531 total - Exercise/Conversion
Common Stock
2025-12-02+10,417→ 468,948 total - Tax Payment
Common Stock
2025-12-02$2.14/sh−4,426$9,472→ 464,522 total - Exercise/Conversion
Restricted Stock Units
2025-12-01−41,669→ 208,344 total→ Common stock (41,669 underlying) - Exercise/Conversion
Restricted Stock Units
2025-12-02−10,417→ 10,418 total→ Common stock (10,417 underlying)
Footnotes (7)
- [F1]Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date.
- [F2]Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities.
- [F3]Represents common stock remaining after deducting the common stock withheld for taxes.
- [F4]Each RSU represents a contingent right to receive one share of the Issuer's common stock.
- [F5]The remaining RSUs will vest in equal quarterly installments.
- [F6]Such aggregate number reflects the remainder of such RSUs granted on March 1, 2024, but does not include any other RSUs held by such Reporting Person.
- [F7]Such aggregate number reflects the remainder of such RSUs granted on March 2, 2023, but does not include any other RSUs held by such Reporting Person.
Documents
Issuer
IOVANCE BIOTHERAPEUTICS, INC.
CIK 0001425205
Entity typeother
Related Parties
1- filerCIK 0001719678
Filing Metadata
- Form type
- 4
- Filed
- Dec 2, 7:00 PM ET
- Accepted
- Dec 3, 5:01 PM ET
- Size
- 15.1 KB